Should You Consider Switching to Wegovy HD?

Wegovy (semaglutide) is helping many people lose a significant amount of weight. But not everyone reaches their weight-loss goals with the standard maintenance doses. Some people may lose weight at first and then hit a plateau. Others may need additional weight loss to help improve weight-related health conditions.

That’s where Wegovy HD may be useful. It’s a higher-dose version of Wegovy that has been shown to provide greater weight loss than standard Wegovy injections.

So how do you know whether switching makes sense? Here’s what to consider.

What is Wegovy HD?

Wegovy HD is a higher-dose form of injectable Wegovy. It contains the same active ingredient as standard Wegovy, semaglutide, but at a higher dose.

With standard Wegovy, the dose is typically increased gradually until you reach a maintenance dose of 2.4 mg once weekly. Wegovy HD contains a 7.2 mg dose of semaglutide. It’s intended for adults who are already using the 2.4 mg dose, tolerating it well, and in need of additional weight loss.

Who should consider switching to Wegovy HD?

Wegovy HD may be worth discussing with your healthcare team if you’re already using Wegovy 2.4 mg and still have additional weight-loss goals.

Wegovy HD may be a good fit if:

• You’ve been using Wegovy 2.4 mg consistently for at least 4 weeks.

• Your weight loss has slowed or plateaued.

• You haven’t reached your treatment goals.

• You’re tolerating the 2.4 mg Wegovy dose well (i.e., experiencing few or mild side effects).

• Additional weight loss could help improve a weight-related health condition.

It’s best to make sure other factors aren’t affecting your progress before switching to Wegovy HD. Your healthcare team may review the following before recommending the higher-dose form:

• Your eating habits

• Your level of physical activity

• What other medications you’re taking

• Your medical history

• How much sleep you’re getting at night

• Your stress levels

Who may not need Wegovy HD?

Not everyone using Wegovy is a candidate for switching to Wegovy HD.

Your prescriber may not recommend Wegovy HD if:

• You’re still losing weight with the 2.4 mg Wegovy dose.

• You’re having bothersome side effects.

• You’ve recently started Wegovy or increased your dose and haven’t given it enough time to work.

Side effects may be more pronounced with Wegovy HD. So it may not be the best option if your current side effects are hard to manage. Instead, your healthcare team may recommend staying at your current dose, adjusting your treatment plan, or considering another weight-loss medication.

How much more weight could you lose?

In clinical trials, people taking Wegovy HD lost about 19% of their starting body weight, on average, by 72 weeks (16.5 months). In the same time frame, those receiving Wegovy 2.4 mg lost about 16% of their body weight on average.

But individual results can vary: Some people may lose more weight, while others may lose less than what was seen in trials. Your results can depend on factors such as your starting body weight, your eating patterns and physical activity level, and how well you tolerate treatment.

It's also helpful to set realistic expectations. Wegovy HD may help some people lose additional weight. But there's no guarantee that weight loss will restart if you've reached a plateau or that you'll lose weight as quickly as you did when you started treatment.

Will side effects get worse?

Your side effects may get worse if you switch to Wegovy HD. The dose is three times higher than the Wegovy maintenance dose of 2.4 mg. Because of this, there’s a higher likelihood of certain side effects. In clinical trials, gastrointestinal side effects and abnormal skin sensations were more common in the Wegovy HD group than in the standard Wegovy group.

Common Wegovy side effects include:

• Nausea

• Vomiting

• Diarrhea

• Constipation

• Stomach pain

• Heartburn

• Decreased appetite

Like standard Wegovy, Wegovy HD also has serious risks, including:

• Low blood glucose (sugar)

• Pancreatitis (inflammation of the pancreas)

• Gallbladder problems

• Kidney damage

• Severe gastrointestinal problems, such as gastroparesis

• Worsening of diabetes-related eye problems

• Bone loss

If you had significant side effects while increasing your Wegovy dose in the past, let your healthcare team know before switching. They can help you weigh the potential benefits of added weight loss against the increased risk of side effects.

How do you switch from Wegovy to Wegovy HD?

You should only switch to Wegovy HD after discussing it with your healthcare team. They will determine whether it’s appropriate based on factors like your current dose, weight-loss progress, and side effects.

In general, Wegovy HD is for people who are already using the Wegovy 2.4 mg dose. Your prescriber may want to confirm that you’ve been using this dose long enough to assess your response, before increasing it.

Before switching, ask your healthcare team:

• How much additional weight loss is realistic for me?

• What side effects should I watch for?

• How often should I follow up after switching?

• Should I make any changes to my diet or exercise routine?

How to save on Wegovy HD

Wegovy HD may cost more than standard Wegovy, and insurance coverage can vary. Before switching, it’s a good idea to check your plan’s coverage details if you have insurance. You should also ask whether prior authorization is required.

There are also several ways to save on Wegovy HD, from GoodRx discounts to manufacturer copay savings cards:

• Save with GoodRx. With a free GoodRx coupon, the price of Wegovy HD is $399 per month. Subscribers to GoodRx for Weight Loss can also access brand-name, FDA-approved medications like Wegovy HD.

• Save with a copay savings card. If you have commercial insurance, you could pay as little as $25 per month with a copay savings card.

• Save with direct pharmacy options. You can pay $399 a month for Wegovy HD, and get it delivered to your home, through NovoCare Pharmacy.

Why trust our experts?

Written by:

Alyssa Billingsley, PharmD

Alyssa Billingsley, PharmD, is the director of pharmacy content for GoodRx. She has over a decade of experience as a pharmacist and has worked in clinical, academic, and administrative roles.

Reviewed by:

Stacia Woodcock, PharmD

Stacia Woodcock, PharmD, is a pharmacy editor for GoodRx. She earned her Doctor of Pharmacy degree from the University of Kentucky and is licensed in New York and Massachusetts.

Our editorial standards

Meet our experts